glp 1 treatment miami GLP-1 Microdosing in GLP-1 Medical Weight Loss -
Description
Confirmatory secondary endpoints evaluated the percentage change in body weight and a reduction in BMI of at least 5%
[DOI] [PubMed] [Google Scholar] 24.Peterson A.C., Russell J.D., Bailey D.J., Westphall M.S., Coon J.J
[ Expert opinion, general recommendation ] Recommendation 2-2) Careful monitoring for complications such as hypoglycemia, hypokalemia, and cerebral edema is required during the treatment of DKA or HHS
Vomiting Often linked with nausea as the body adjusts to the medication
There were no cases consistent with drug-induced liver injury/Hy's Law with orforglipron
